SBC Medical Group Holdings Incorporated Interest Expense Nonoperating
SBC Medical Group Holdings Incorporated (SBC) reported Interest Expense Nonoperating of $128.63 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated interest expense nonoperating for the quarter ending 2026-06-30 was $128.63K, a 159.07% increase year-over-year.
- SBC Medical Group Holdings Incorporated interest expense nonoperating for the quarter ending 2026-03-31 was $114.81K, a 1749.62% increase year-over-year.
- SBC Medical Group Holdings Incorporated interest expense nonoperating for the quarter ending 2025-12-31 was $56.09K, a 352.27% increase year-over-year.
- SBC Medical Group Holdings Incorporated interest expense nonoperating for the quarter ending 2025-09-30 was $48.63K, a 789.77% increase year-over-year.
- SBC Medical Group Holdings Incorporated interest expense nonoperating for fiscal 2025 was $160.58K, a 467.43% increase from fiscal 2024.
- SBC Medical Group Holdings Incorporated interest expense nonoperating for fiscal 2024 was $28.30K, a 37.52% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated interest expense nonoperating for fiscal 2023 was $45.29K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $128.63K 10-Q · filed 2026-08-13 | $243.44K 10-Q · filed 2026-08-13 | $299.52K derived: sum of 3 quarters · filed 2026-08-13 | $348.16K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $114.81K 10-Q · filed 2026-05-14 | $170.90K derived: sum of 2 quarters · filed 2026-05-14 | $219.53K derived: sum of 3 quarters · filed 2026-05-14 | $269.18K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $56.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $104.72K derived: sum of 2 quarters · filed 2026-03-27 | $154.38K derived: sum of 3 quarters · filed 2026-08-13 | $160.58K 10-K · filed 2026-03-27 |
| 2025-09-30 | $48.63K 10-Q · filed 2025-11-14 | $98.29K derived: sum of 2 quarters · filed 2026-08-13 | $104.49K 10-Q · filed 2025-11-14 | $116.89K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $49.65K 10-Q · filed 2026-08-13 | $55.86K 10-Q · filed 2026-08-13 | $68.26K derived: sum of 3 quarters · filed 2026-08-13 | $73.73K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $6.21K 10-Q · filed 2026-05-14 | $18.61K derived: sum of 2 quarters · filed 2026-05-14 | $24.07K derived: sum of 3 quarters · filed 2026-05-14 | $31.50K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $12.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $17.87K derived: sum of 2 quarters · filed 2026-03-27 | $25.29K derived: sum of 3 quarters · filed 2026-03-27 | $28.30K 10-K · filed 2026-03-27 |
| 2024-09-30 | $5.47K 10-Q · filed 2025-11-14 | $12.89K derived: sum of 2 quarters · filed 2025-11-14 | $15.90K 10-Q · filed 2025-11-14 | $23.81K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $7.42K 10-Q · filed 2025-08-13 | $10.43K 10-Q · filed 2025-08-13 | $18.34K derived: sum of 3 quarters · filed 2025-08-13 | $22.32K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $3.01K 10-Q · filed 2025-05-15 | $10.92K derived: sum of 2 quarters · filed 2025-05-15 | $14.90K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $7.91K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $11.89K derived: sum of 2 quarters · filed 2025-03-28 | $45.29K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $3.98K 10-Q · filed 2024-11-13 | $37.38K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |